CardioLogs ECG Analysis Platform vs CAC Software

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CardioLogs (acquired by Philips in 2021)
VS
by 4DMedical (Imbio CAC Software)

AI Verdict

These tools are adjacent rather than direct competitors, as they address different aspects of cardiac diagnostics. Tool A specializes in AI-powered analysis of ECG data for arrhythmia detection, while Tool B focuses on quantifying coronary artery calcification from CT scans to assess coronary artery disease risk. Physicians would likely use them for distinct diagnostic purposes based on the type of cardiac data available and the specific condition being investigated.

Choose CardioLogs ECG Analysis Platform if…

Choose CardioLogs ECG Analysis Platform if your primary need is rapid, AI-driven detection and diagnosis of cardiac arrhythmias from a wide range of ECG monitoring devices, including Holters, smartwatches, and ECG patches. This platform is ideal for cardiology, emergency medicine, and internal medicine practices seeking to streamline ECG interpretation and enhance diagnostic accuracy through cloud-based, medical-grade AI.

View CardioLogs ECG Analysis Platform →

Choose CAC Software if…

Choose Imbio's CAC Software if you require automated, quantitative analysis of coronary artery calcification from non-contrast chest CT scans to assess a patient's risk for coronary artery disease. This tool is best suited for radiologists and cardiologists looking to integrate deep-learning based image post-processing into their existing DICOM workflow to obtain precise Agatston scores, arterial age, and 3D visualizations.

View CAC Software →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CardioLogs ECG Analysis Platform CAC Software
Deployment Cloud-based Cloud-based (SaaS), integrates with PACS
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CardioLogs ECG Analysis Platform

CardioLogs emphasizes 'rapid, accurate, and efficient analysis' and 'real-time monitoring/analysis,' suggesting a highly streamlined user experience. Its multi-device compatibility, including smartwatches, offers greater flexibility in data input compared to Imbio's CT-based analysis.

Clinical Value

Tie

Both tools offer significant clinical value in their respective domains, with FDA clearance confirming their medical utility. CardioLogs aids in arrhythmia detection and diagnosis from ECGs, while Imbio CAC quantifies coronary artery calcification for CAD risk assessment from CTs. They address different, but equally important, clinical needs.

Pricing & Value

CardioLogs ECG Analysis Platform

CardioLogs provides a clearer pricing model by stating 'Pay per ECG regardless of the number of users,' which offers some transparency into the cost structure. Imbio CAC only states 'contact for pricing,' providing no insight into its model. While both require contacting sales for a quote, Tool A's model is more defined.

Enterprise Readiness

CardioLogs ECG Analysis Platform

Both tools are FDA-cleared, HIPAA compliant, and offer BAA. However, CardioLogs, as a Philips solution, benefits from Philips' extensive enterprise infrastructure, robust security (ISO/IEC 27001 certified AWS servers), and established EHR integration capabilities. While Imbio offers deployment flexibility (cloud, on-premise, partner platforms), Philips' backing provides a stronger overall enterprise readiness profile.

Innovation

CardioLogs ECG Analysis Platform

Both leverage deep learning for medical analysis. CardioLogs stands out with its 'medical-grade AI and cloud technology' for ECG analysis, particularly its multi-device compatibility including smartwatches, which pushes the boundaries of continuous cardiac monitoring and early detection.

Support & Docs

CardioLogs ECG Analysis Platform

As a Philips solution, CardioLogs benefits from Philips' well-established global support infrastructure, including dedicated support centers, online portals, and extensive documentation for healthcare professionals. Imbio also offers support, including phone and email, and provides user manuals upon request, but the scale and breadth of Philips' support network are likely more comprehensive.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CardioLogs ECG Analysis Platform CAC Software
Name CardioLogs ECG Analysis Platform CAC Software
Company Cardiologs Technologies (now part of Philips) Imbio
Description The Cardiologs ECG Analysis Platform, now a Philips solution, uses medical-grade AI and cloud technology for rapid, accurate, and efficient analysis of ECG data from various cardiac monitoring devices, aiding physicians in arrhythmia detection and diagnosis. Imbio's Coronary Artery Calcification (CAC) software is a set of automated image post-processing algorithms designed to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries in patients who have undergone a non-contrast, chest computed tomography (CT).
Key Functionality AI-Powered ECG Analysis (Deep Neural Networks), Automated Arrhythmia Detection (e.g., AFib, VT) Automated image post-processing for coronary artery calcification, Quantification of calcification within coronary arteries
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Radiology
Data Input ECG data from various cardiac monitoring devices (Holter, smartwatches, ECG patches) Non-contrast, chest computed tomography (CT) scans

Videos

Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and CAC Software.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

CardioLogs ECG Analysis Platform is designed for rapid, accurate, and efficient analysis of ECG data to aid physicians in arrhythmia detection and diagnosis. Imbio's CAC Software, on the other hand, uses automated image post-processing algorithms to determine the location and quantify calcification within the coronary arteries from non-contrast chest CT scans, supporting risk assessment for coronary artery disease.
CardioLogs ECG Analysis Platform analyzes ECG data from various cardiac monitoring devices, including Holter monitors, smartwatches, and ECG patches. Imbio's CAC Software analyzes non-contrast chest computed tomography (CT) scans to identify and quantify coronary artery calcification.
CardioLogs ECG Analysis Platform provides AI-powered automated arrhythmia detection, such as AFib and VT, and generates customizable reports. Imbio's CAC Software outputs include the Agatston score, arterial age, calcified lesion mass and volume, 3D visualizations, and annotated images.
CardioLogs ECG Analysis Platform is intended for use by cardiologists, emergency medicine physicians, and internal medicine specialists. Imbio's CAC Software is designed to assist both cardiologists and radiologists in their assessments.
CardioLogs ECG Analysis Platform uses a 'pay per ECG' pricing model, regardless of the number of users. For Imbio's CAC Software, pricing information requires contacting their sales department for a quote.
CardioLogs ECG Analysis Platform offers integration with EHR Systems. Imbio's CAC Software is designed to integrate into existing DICOM viewing workflows and can automatically send outputs to PACS.
AI Tool Finder
AI-powered search. Results may not be comprehensive.